Ara
Toplam kayıt 180, listelenen: 21-30
Preoperative Cardiac Risk Assessment in Patients Undergoing Liver Transplant Due to Hepatocellular Carcinoma: Should It Be Different?
(2017)
Objectives: Liver transplant is a high-risk surgery for cardiac events. The risk of 30-day major cardiac adverse events is estimated at more than 5%. In this retrospective study, we evaluated our preoperative cardiac risk ...
Expanded Criteria for Hepatocellular Carcinoma in Liver Transplant
(2017)
Objectives: Hepatocellular carcinoma is the sixth most common cancer worldwide and is the third highest cause of malignancy-related death. Because of its typically late diagnosis, median survival is ap proximately 6 to 20 ...
Incisional Hernia After Liver Transplant
(2017)
Objectives: An incisional hernia seriously burdens the quality of life after liver transplant. The incidence of incisional hernia after liver transplant is reported to be 4% to 20%. Here, we evaluated incisional hernias ...
Unusual Indications for a Liver Transplant: A Single-Center Experience
(2017)
Objectives: This study sought to evaluate the efficacy of liver transplant for unusual liver diseases.
Materials and Methods: The results of 476 patients who underwent liver transplant from 1988 to January 2015 were ...
Vascular Complications After Renal Transplant: A Single-Center Experience
(2017)
Objectives: Despite surgical and medical advances, vascular complications are still among the major concerns after renal transplant, with a reported incidence of 3% to 15%. We evaluated the incidence and management of our ...
Low-Grade Persistent Hyperparathyroidism After Pediatric Renal Transplant
(2016)
Objectives: Hyperparathyroidism, a frequent com-plication of chronic kidney disease, persists after renal transplant. Our aims were to examine the status of parathyroid hormone levels and to determine the clinical and ...
Auxiliary Partial Orthotopic Living Liver Transplant for Wilson Disease
(2017)
Wilson disease is a genetic disease involving copper metabolism disturbances that result in copper accumulations, especially in the liver and brain. Wilson disease can be treated with pharmacologic agents, such as chelators ...